Literature DB >> 8182154

Downregulation of adenylylcyclase types V and VI mRNA levels in pacing-induced heart failure in dogs.

Y Ishikawa1, S Sorota, K Kiuchi, R P Shannon, K Komamura, S Katsushika, D E Vatner, S F Vatner, C J Homcy.   

Abstract

We have shown that the heart expresses two distinct forms of adenylylcyclase mRNA, types V and VI. In this study we have characterized the expression of these two mRNA species in heart failure generated by overdrive pacing at a rate of 240 beats/min. After 4 wk, left ventricular end-diastolic pressure and heart rate increased significantly with the appearance of signs of heart failure, i.e., edema, ascites, and exercise intolerance. Basal as well as forskolin-stimulated adenylylcyclase activities decreased significantly, which was accompanied by a reduction in the steady state mRNA levels of adenylylcyclase types V and VI. These data suggest that in this model of cardiomyopathy, the downregulation of adenylylcyclase catalytic activity results, at least in part, from a reduction in the steady state levels of types V and VI adenylylcyclase mRNA levels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8182154      PMCID: PMC294370          DOI: 10.1172/JCI117219

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Selective gene expression in failing human heart. Quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction.

Authors:  A M Feldman; P E Ray; C M Silan; J A Mercer; W Minobe; M R Bristow
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

2.  Expression and characterization of calmodulin-activated (type I) adenylylcyclase.

Authors:  W J Tang; J Krupinski; A G Gilman
Journal:  J Biol Chem       Date:  1991-05-05       Impact factor: 5.157

Review 3.  Beta-adrenergic receptor regulation in the heart in pathophysiologic states: abnormal adrenergic responsiveness in cardiac disease.

Authors:  C J Homcy; S F Vatner; D E Vatner
Journal:  Annu Rev Physiol       Date:  1991       Impact factor: 19.318

4.  Adenylyl cyclase amino acid sequence: possible channel- or transporter-like structure.

Authors:  J Krupinski; F Coussen; H A Bakalyar; W J Tang; P G Feinstein; K Orth; C Slaughter; R R Reed; A G Gilman
Journal:  Science       Date:  1989-06-30       Impact factor: 47.728

5.  Reversibility of tachycardia-induced cardiomyopathy after cure of incessant supraventricular tachycardia.

Authors:  F E Cruz; E C Cheriex; J L Smeets; J Atié; A K Peres; O C Penn; P Brugada; H J Wellens
Journal:  J Am Coll Cardiol       Date:  1990-09       Impact factor: 24.094

6.  Identification of a specialized adenylyl cyclase that may mediate odorant detection.

Authors:  H A Bakalyar; R R Reed
Journal:  Science       Date:  1990-12-07       Impact factor: 47.728

7.  One hour of myocardial ischemia decreases the activity of the stimulatory guanine-nucleotide regulatory protein Gs.

Authors:  E E Susanni; W T Manders; D R Knight; D E Vatner; S F Vatner; C J Homcy
Journal:  Circ Res       Date:  1989-10       Impact factor: 17.367

8.  Dysfunction of the beta- and alpha-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog.

Authors:  A Calderone; M Bouvier; K Li; C Juneau; J de Champlain; J L Rouleau
Journal:  Circ Res       Date:  1991-08       Impact factor: 17.367

9.  Decreased Gs alpha mRNA levels accompany the fall in Gs and adenylyl cyclase activities in compensated left ventricular hypertrophy. In heart failure, only the impairment in adenylyl cyclase activation progresses.

Authors:  L A Chen; D E Vatner; S F Vatner; L Hittinger; C J Homcy
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

10.  Decreased stimulatory guanosine triphosphate binding protein in dogs with pressure-overload left ventricular failure.

Authors:  J P Longabaugh; D E Vatner; S F Vatner; C J Homcy
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

View more
  23 in total

1.  Intracoronary Gene Transfer of Adenylyl Cyclase 6 in Patients With Heart Failure: A Randomized Clinical Trial.

Authors:  H Kirk Hammond; William F Penny; Jay H Traverse; Timothy D Henry; Matthew W Watkins; Clyde W Yancy; Ranya N Sweis; Eric D Adler; Amit N Patel; David R Murray; Robert S Ross; Valmik Bhargava; Alan Maisel; Denise D Barnard; N Chin Lai; Nancy D Dalton; Martin L Lee; Sanjiv M Narayan; Daniel G Blanchard; Mei Hua Gao
Journal:  JAMA Cardiol       Date:  2016-05-01       Impact factor: 14.676

2.  Down regulation of myocardial beta1-adrenoceptor signal transduction system in pacing-induced failure in dogs with aortic stenosis-induced left ventricular hypertrophy.

Authors:  J Tse; M W Huang; R J Leone; H R Weiss; Y Q He; P M Scholz
Journal:  Mol Cell Biochem       Date:  2000-02       Impact factor: 3.396

Review 3.  Modification of beta-adrenoceptor signal transduction pathway by genetic manipulation and heart failure.

Authors:  X Wang; N S Dhalla
Journal:  Mol Cell Biochem       Date:  2000-11       Impact factor: 3.396

Review 4.  Unanticipated signaling events associated with cardiac adenylyl cyclase gene transfer.

Authors:  Mei Hua Gao; H Kirk Hammond
Journal:  J Mol Cell Cardiol       Date:  2011-02-23       Impact factor: 5.000

5.  Study of adenylyl cyclase-GαS interactions and identification of novel AC ligands.

Authors:  Appalaraju Jaggupilli; Premnath Dhanaraj; Alexander Pritchard; John L Sorensen; Shyamala Dakshinamurti; Prashen Chelikani
Journal:  Mol Cell Biochem       Date:  2018-01-11       Impact factor: 3.396

6.  Increased expression of adenylylcyclase type VI proportionately increases beta-adrenergic receptor-stimulated production of cAMP in neonatal rat cardiac myocytes.

Authors:  M Gao; P Ping; S Post; P A Insel; R Tang; H K Hammond
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

7.  Epac1-dependent phospholamban phosphorylation mediates the cardiac response to stresses.

Authors:  Satoshi Okumura; Takayuki Fujita; Wenqian Cai; Meihua Jin; Iyuki Namekata; Yasumasa Mototani; Huiling Jin; Yoshiki Ohnuki; Yayoi Tsuneoka; Reiko Kurotani; Kenji Suita; Yuko Kawakami; Shogo Hamaguchi; Takaya Abe; Hiroshi Kiyonari; Takashi Tsunematsu; Yunzhe Bai; Sayaka Suzuki; Yuko Hidaka; Masanari Umemura; Yasuhiro Ichikawa; Utako Yokoyama; Motohiko Sato; Fumio Ishikawa; Hiroko Izumi-Nakaseko; Satomi Adachi-Akahane; Hikaru Tanaka; Yoshihiro Ishikawa
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

8.  Vidarabine, an anti-herpesvirus agent, prevents catecholamine-induced arrhythmias without adverse effect on heart function in mice.

Authors:  Kenji Suita; Takayuki Fujita; Wenqian Cai; Yuko Hidaka; Huiling Jin; Rajesh Prajapati; Masanari Umemura; Utako Yokoyama; Motohiko Sato; Björn C Knollmann; Satoshi Okumura; Yoshihiro Ishikawa
Journal:  Pflugers Arch       Date:  2018-02-16       Impact factor: 3.657

Review 9.  Gene transfer for congestive heart failure: update 2013.

Authors:  Tong Tang; H Kirk Hammond
Journal:  Transl Res       Date:  2012-12-20       Impact factor: 7.012

10.  Inhibition of Na+/H+-exchanger with sabiporide attenuates the downregulation and uncoupling of the myocardial beta-adrenoceptor system in failing rabbit hearts.

Authors:  Kirsten Leineweber; Stephanie Aker; Anja Beilfuss; Heike Rekasi; Ina Konietzka; Claus Martin; Gerd Heusch; Rainer Schulz
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.